IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLoon, L. K.
Right arrow Articles by Wirtschafter, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLoon, L. K.
Right arrow Articles by Wirtschafter, J.

Investigative Ophthalmology & Visual Science, Vol 34, 3450-3458, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Regional differences in the subacute response of rabbit orbicularis oculi to bupivacaine-induced myotoxicity as quantified with a neural cell adhesion molecule immunohistochemical marker

LK McLoon and J Wirtschafter
Department of Ophthalmology, University of Minnesota, Minneapolis 55455.

PURPOSE. This study examined the subacute myotoxic effects of injection of the local anesthetic bupivacaine on the orbicularis oculi muscle in the rabbit eyelid. In contrast to other muscles, the orbicularis oculi was resistant to injury by the usual anesthetic doses of bupivacaine when local infiltration is used. An attempt was made to assess the sensitivity of orbicularis oculi muscle to bupivacaine using a variety of increased bupivacaine concentrations and in combination with hyaluronidase. METHODS. Bupivacaine was injected into rabbit lower eyelids at a variety of doses with and without the injection of hyaluronidase before bupivacaine treatment. Muscle injury was assessed immunohistochemically using an antibody to an isoform of neural cell adhesion molecule, anti-leu-19, a molecule shown to localize on the surface of regenerating muscle fibers. The number of neural cell adhesion molecule-positive muscle fibers was assessed 4 and 7 days after bupivacaine injection to determine the number of fibers that were injured. RESULTS. When bupivacaine was injected into the lower eyelid at a dose of 1.5 mg, only 10% of the orbicularis oculi muscle was injured. The most effective injury involved either multiple injections of 3 mg bupivacaine or of hyaluronidase 20 minutes before the injection of 3 mg bupivacaine, resulting in injury of up to 58% of the muscle fibers. In all cases, the preseptal region of the orbicularis oculi showed a greater percentage of injury than the pretarsal portions of the muscle. CONCLUSIONS. Although multiple injections of bupivacaine and bupivacaine combined with hyaluronidase significantly increased the percentage of muscle cells injured, total destruction of the orbicularis oculi muscle was never seen. Neural cell adhesion molecule was a good marker for the quantification of the regenerating muscle fibers. It is proposed that the tight fasciculation of the orbicularis oculi muscle may play a role in preventing access of the local anesthetic to the individual muscle fibers. This demonstrates the relative clinical safety of local anesthetic injection into the eyelid.


This article has been cited by other articles:


Home page
 IOVSHome page
L. K. McLoon and J. D. Wirtschafter
Direct Injection of Liposome-Encapsulated Doxorubicin Optimizes Chemomyectomy in Rabbit Eyelid
Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2561 - 2567.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology